Skip to search formSkip to main contentSkip to account menu

Varlitinib Tosylate

Known as: ARRY-543 Ditosilate, 4-N-(3-Chloro-4-(Thiazol-2-Ylmethoxy)Phenyl)-6-N-((4r)-4-Methyl-4,5-Dihydrooxazol-2- Yl)Quinazoline-4,6-Diamine Bis(4-Methylbenzenesulphonate), 4,6-Quinazolinediamine, N(Sup 4)-(3-Chloro-4-(2-Thiazolylmethoxy)Phenyl)-N(Sup 6)-((4r)-4,5-Dihydro-4-Methyl-2-Oxazolyl)-, 4-Methylbenzenesulphonate (1:2) 
The tosylate salt form of varlitinib, an orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
  • 2015
  • Corpus ID: 56423727
The synthesis and characterization of chromogenic and fluorogenic crown ethers, derived from 4-aza dibenzo 18-crown-6 ether is… 
2011
2011
L'invention porte sur le procede pour la preparation de lapatinib et de sels pharmaceutiquement acceptables de celui-ci par l… 
2009
2009
Abstract #4054 The anti-tumor effect of HER2 antagonists in HER2-dependent breast cancer cells has been proposed to rely on… 
2001
2001
The invention relates to a method for treating the crystallized characteristic disease by at least erbB-based PTK activity using… 
1989
1989
The dissolution inhibition effect and alkaline solubility were investigated for naphthoquinone diazides like 1,2-naphthoquinone…